Tag: Kidney Problems: Misc.
Dapagliflozin May Be Cost-Effective for Treating CKD
Dapagliflozin for the treatment of chronic kidney disease cost-effective at willingness-to-pay thresholds of $27,510 and $35,503 per QALY in U.K. and Germany, Spain
Benefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
Stroke patients with normal, but not those with impaired, renal function have greater benefit with ticagrelor-aspirin than clopidogrel-aspirin
Psoriasis Not Tied to Myocardial Infarction in Patients With ESRD
Confounding variables, particularly comorbidities, impact association
Trajectories of CKD Symptoms May Predict Later Health Outcomes
Participants with worse symptoms score and in worsening trajectory group had worse quality of life, higher risk for kidney replacement therapy
Regular Aerobic Exercise May Improve Chronic Kidney Disease Outcomes
Improvements seen in estimated glomerular filtration rate, serum creatinine, 24-hour urine protein amount, and blood urea nitrogen
Factors Linked to Self-Care Behavior ID’d for CKD Patients
Not currently working, nonsmoker, end-stage kidney disease significantly affect self-care behavior
Race-Free Creatinine Equation May Cut Disparity in Kidney Wait Time
Racial disparities in preemptive wait time accrual may be reduced with use of the 2021 creatinine-based CKD-EPI equation
CKD Risk Up for Metabolically Healthy Overweight, Obese People
Risk for chronic kidney disease progressively higher in overweight and obese versus normal-weight metabolically healthy individuals
Intervention Cuts Risk for AKI After Coronary Angiography
Reduced incidence of AKI seen in association with multifaceted intervention, including clinical decision support, audit, feedback
Outcomes of Living, Unrelated Donor Kidney Transplants in Children Examined
Graft survival comparable for living unrelated donor, living related donor kidney recipients
